How to Buy Protalix Biotherapeutics Stock
Protalix Biotherapeutics Inc
Protalix BioTherapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally.
Protalix Biotherapeutics stock last closed at $1.16, down 4.13% from the previous day, and has decreased 56.06% in one year. It has underperformed other stocks in the Biotechnology industry by 0.38 percentage points. Protalix Biotherapeutics stock is currently +6.42% from its 52-week low of $1.09, and -67.32% from its 52-week high of $3.55.
As of May 2, 2024, there are 73.05M PLX shares outstanding. The market cap of PLX is $84.74M. In the past 24 hours, 218,873 PLX shares were traded.
How to Buy Protalix Biotherapeutics Stock
Not sure how to invest in Protalix Biotherapeutics stock? Here's how.
- Choose where to buy Protalix Biotherapeutics stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Protalix Biotherapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Select your method of payment and add your details.
- Research Protalix Biotherapeutics stock: The Protalix Biotherapeutics ticker symbol is PLX. Is Protalix Biotherapeutics stock a good investment? Should you buy shares of PLX? How do PLX's underlying business fundamentals look? Do top analysts think Protalix Biotherapeutics is a good buy? Why has PLX's stock price moved recently? (Hint: Our stock research tools can help you evaluate if PLX is a good stock to buy).
- Place your PLX purchase: Decide if you will purchase PLX shares at the current market price or use a limit order to purchase PLX shares at a particular price.
- Track your investment in PLX: Create a watchlist to keep track of your investment in Protalix Biotherapeutics shares.
Step 1: Choose where to buy Protalix Biotherapeutics stock
You need an online brokerage account to access the NYSEMKT market and buy PLX shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal information so you are able to buy PLX stock today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to open your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have created your account on the best stock app, you can securely and quickly fund your account:
Watch the video below to see the process of depositing money into your investment account.
Step 4: Research Protalix Biotherapeutics stock
Once you have decided on the best place to buy Protalix Biotherapeutics stock, it's important to analyze their stock before you buy, so you actually understand the risk and upside.
Protalix Biotherapeutics Metrics
Fundamentals of PLX
WallStreetZen was created to help average investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on PLX's stock page.
Is PLX stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge PLX's fair value.
Using relative valuations measures:
- PLX could be overvalued based on its P/E ratio of 9.67x, relative to Biotechnology industry P/E ratio of 7.63x
- PLX could be undervalued based on its P/B ratio of 2.52x, relative to Biotechnology industry P/B ratio of 5.99x
You can do more valuation research on PLX's stock here.
How do PLX Financials look?
Passed Financial Due Diligence Checks:
- Total PLX debt is lower than 5 years ago, relative to shareholder equity.
- PLX has cash burn of 2467000. It has sufficient cash and short-term investments to cover this for at least one year.
- PLX profit margin has gone up from -31.3% to 12.7% in the past year.
- PLX has $44.56M in cash and short term investments. This is sufficient to cover its annual cash burn of $2.47M.
- There are more short-term assets than long-term liabilities on the PLX balance sheet.
- There are more short-term assets than short-term liabilities on the PLX balance sheet.
Failed Financial Due Diligence Checks:
- PLX has a relatively high debt to equity ratio of 1.52.
Is PLX stock a Buy, Hold, or Sell, according to analysts?
Out of 1 sell side analysts who track PLX, the consensus analyst rating on PLX is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Protalix Biotherapeutics stock forecast page.
PLX Technical Indicators
How are PLX Revenues/Earnings doing?
Last year, PLX revenue was $65.49M. In the past 5 year, PLX's revenue has grown by 13.85% per year. This was slower than the Biotechnology industry average of 29.57%.
You can research PLX's earnings and revenue performance here.
What are PLX executives and large shareholders up to?
In the past year, executives and large shareholders at PLX have bought more shares than they have sold.
Dror Bashan, PRESIDENT AND CEO of PLX, was the latest PLX insider to buy. They bought $22,741.89 worth of PLX shares on Oct 19, 2023.
Get more info about who owns PLX stock here.
Can I get consistent income from PLX stock?
No, Protalix Biotherapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your PLX purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open button and your broker will execute the order.
If you want additional info about investing in stocks on eToro, click the how to video below:
Step 6: Track your investment in PLX
Now that you own some PLX stock, you'll want to keep up with your shares.
Start a watchlist to get notified of important updates regarding your PLX stock.
PLX Feed
How to Buy Stock in Protalix Biotherapeutics
To reiterate, here are the 6 steps to buy stock in Protalix Biotherapeutics:
- Choose where to buy Protalix Biotherapeutics stock
- Open a brokerage account
- Deposit money your investment account
- Research Protalix Biotherapeutics stock
- Place your PLX purchase
- Track your investment in PLX
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Protalix Biotherapeutics, add PLX to your watchlist below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.